15966 Rates of malignancies through 5 years of tildrakizumab exposure in 2 phase 3 clinical trials Jennifer Cather,Beatrice Nardone,Jeff Parno,Alan M. Mendelsohn,Stephen J. Rozzo,Elizabeth ErgenJournal of The American Academy of Dermatology（2020）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
